Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment

Clinical and Experimental Nephrology

Volumn 9, Issue 2, 2005, Pages 148-152

  Yamamoto, Ryo ^a   Otsuka, Yasushi ^a   Nakayama, Masaaki ^a   Maruyama, Yukio ^a   Katoh, Naohiko ^a   Ikeda, Masato ^a   Yamamoto, Hiroyasu ^a   Yokoyama, Keitaro ^a   Kawaguchi, Yoshindo ^a   Matsushima, Masato ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Encapsulating peritoneal sclerosis (EPS); Peritoneal dialysis (PD); Risk factor

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CREATININE BLOOD LEVEL; DIALYSATE; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEMBRANE TRANSPORT; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL SCLEROSIS; PERITONITIS; RISK FACTOR; SCLEROSIS; SEX ROLE; SOCIAL ASPECT; STATISTICAL SIGNIFICANCE;

ADULT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SCLEROSIS;

EID: 21044438938     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-005-0349-8     Document Type: Article

References (27)

1. VC Gandhi HM Humayun TS Ing JT Daugirdas VR Jablokow S Iwatsuki 1980 Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients Arch Intern Med 140 1201 3
2. Y Nomoto Y Kawaguchi H Kubo H Hirano S Sakai K Kurokawa 1998 Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a case report of the Japanese Sclerosing Encapsulating Peritoneal Study Group Am J Kidney Dis 28 420 7
3. H Kawanishi Y Kawaguchi 2000 Prevalence and therapeutic outcome of sclerosing encapsulating peritonitis (SEP). A multicenter study in Japan (in Japanese) Jin To Touseki (Kidney Dial) 49 s1 225 8
4. H Kawanishi Y Kawaguchi H Fukui S Hara A Imada H Kubo 2004 Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study Am J Kidney Dis 44 729 37
5. IE Afthentopoulous P Passadakis DG Oreopoulos 1998 Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patient: one centers experience and review of the literature Adv Ren Replace Ther 5 157 67
6. M Flanigan D Anderson RM Freeman 1984 Peritoneal dialysis complicated by fungal peritonitis and peritoneal fibrosis Am J Med 76 A113 25
7. CG Chew AR Clarkson RJ Faull 1997 Relapsing CAPD peritoneal sclerosis due to Haemophilus influenzae Nephrol Dial Transplant 12 821 2
8. Brown P, Baddeley H, Read AE, Davies JD, McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet 1974;II:1477-81
9. Oreopoulos DG, Khanna R, Wu G. Sclerosing obstructive peritonitis after CAPD (letter). Lancet 1983;II:409
10. A Slingeneyer C Mion G Mourad B Canaud B Faller JJ Breraud 1983 Progressive sclerosing peritonitis: a late severe complication of maintenance peritoneal dialysis Trans Am Soc Artif Intern Organs 29 633 40
11. BRJ Junor JD Briggs MA Forwell JW Dobbie I Henderson 1985 Sclerosing peritonitis: the contribution of chorhexidine in alcohol Perit Dial Bull 5 101 4
12. M Nakayama 2001 The greater incidence of encapsulating peritoneal sclerosis is not the result of overdiagnosis Perit Dial Int 21 s3 S72 4
13. RJ Rigby CM Hawley 1998 Sclerosing peritonitis: the experience in Australia Nephrol Dial Transplant 13 154 9
14. M Nakayama M Ikeda N Katoh H Hayakawa M Numata Y Otsuka 2002 Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal (in Japanese Nippon Jinzo Gakkai Shi (Jpn J Nephrol) 44 396 401
15. R Yamamoto M Nakayama T Hasegawa N Miwako H Yamamoto K Yokoyami 2002 High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment Adv Perit Dial 18 131 4
16. M Nakayama H Yamamoto M Ikeda T Hasegawa N Kato H Takahashi 2002 Risk factors and preventive measures for encapsulating peritoneal sclerosis - Jikei experience 2002 Adva Perit Dial 18 144 8
17. Y Kawaguchi H Kawanishi S Mujais N Topley DG Oreopoulos 2000 Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis Perit Dial Int 20 s4 S43 55
18. Nakayama M, Yamamoto H, Terawaki H, Oi K, Kamijyo T, Yokoyama K, et al. Longitudinal changes of peritoneal permeability after withdrawal from long-term CAPD treatment. A preliminary study to explore the peritoneal pathophysiology after CAPD treatment (in Japanese). J Jpn Soc Dial Ther 33:1137-42, 200
19. M Numata M Nakayama S Nimura M Kawakami B Lindholm Y Kawaguchi 2003 Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate Perit Dial Int 23 116 22
20. M Goldman P Vandenabeele J Moulart Z Amraoui D Abramowicz J Nortier 1990 Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis Nephron 56 277 80
21. D Zemel RT Krediet 1996 Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability Blood Purif 14 198 216
22. M Nakayama Y Kawaguchi K Yamada T Hasegawa K Takazoe N Katoh 1997 Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD Kidney Int 51 182 6
23. M Nakayama A Sakai M Numata T Hosoya 2003 Hyper-vascular change and formation of advanced glycation endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite Am J Nephrol 23 390 4
24. R Inagi T Miyata T Yamamoto D Suzuki K Urakami A Saito 1999 Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis FEBS Lett 463 260 4
25. B Musi M Braide A Wieslander A Rippe A Albrektsson T Henle 2001 Very high daily intraperitoneal doses of carbonyl compounds affect the morphology, but not the exchange characteristics, of rat peritoneum Blood Purif 19 286 92
26. G Garosi N Di Paolo 2000 Peritoneal sclerosis: one or two nosological entities Semin Dial 13 297 308
27. M Numata M Nakayama T Hosoya CM Hoff CJ Holmes M Schalling 2004 Possible pathological involvement of receptor for advanced glycation endproducts (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients Clin Nephrol 62 455 60